Drug intelligence / Profile preview

Bell's Calamine Lotion

Development stage: Unknown
Lead developer: Bell's Healthcare
Modality: Small Molecules
Administration: Topical

Overview

Bell's Calamine Lotion is an over-the-counter topical formulation developed by Bell's Healthcare. It contains a combination of calamine (15% w/v) and zinc oxide (5% w/v) in a base formulated to British Pharmacopoeia (B.P.) standards. The lotion is indicated for the relief of minor skin irritations, including sunburn, dermatitis, eczema, and slight abrasions. It functions through physical mechanisms: providing a cooling sensation via evaporation to alleviate pain and swelling, acting as a mild astringent, and forming a protective barrier over sensitive or abraded skin. It is manufactured in the UK in GMP/MHRA approved facilities and is suitable for adults and children aged 1 year and above.

Brand names: Bell's Calamine Lotion
Other names: Calamine Lotion B.P.

Beyond the preview

Go deeper on Bell's Calamine Lotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bell's Calamine Lotion.

Explore the full profile